Ask A Lawyer
Talk to a Keppra Lawyer for a free case review.
Levetiracetam (LVT) is the active ingredient in the brand and Mylan generic anti epileptic drug (AED).
LVT is a second-generation AED used to prevent or reduce the occurrence of seizures in people with epilepsy. Second-generation AEDs are thought to be better tolerated and safer than first-generation AEDs. Second-generation AEDs have different pharmacokinetic profiles and mechanisms of action when compared to first-generation AEDs.
LVT binds to the synaptic vesicle protein SV2A, which is believed to be involved in the regulation of nerve conduction across synapses. This differentiates LVT from other anti epileptic drugs.
Epilepsy is a chronic condition characterized by recurring, unprovoked seizures. The cause of these seizures is generally believed to be excessive electrical discharge of neurons in the brain.
Seizures are generally classified as either partial or generalized. Partial seizures are brought on by activity in just one of cerebral hemispheres, whereas generalized seizures are brought on by activity in both hemispheres.
According to the Epilepsy Foundation, epilepsy and seizures affect approximately 3 million Americans, costing $12.5 billion annually.
Do you have epilepsy?
- Have you or a loved one suffered seizures after taken Mylan generic AED?
- Has a pharmacy refilled your AED prescription with a generic product without your knowledge or your doctor’s knowledge?
If you answered yes to any of the above – please contact Monheit Law for a free legal consultation to find how what your legal options are.